167 related articles for article (PubMed ID: 34719614)
1. Effect of Hyperbaric Oxygen Therapy (HBOT) on Insulin Resistance Associated with Abdominal Obesity in Wistar Rats with Dietary Sucrose-Induced Metabolic Syndrome.
Cruz-Villanueva SR; Ramirez-Nava JC; Moreno-Luna JA; Cárdenas-Ureña KG; Espín-Iturbe LT; Sánchez Otero MG; Quintana-Castro R; Alexander-Aguilera A
J Nutr Sci Vitaminol (Tokyo); 2021; 67(5):292-300. PubMed ID: 34719614
[TBL] [Abstract][Full Text] [Related]
2. Hyperbaric oxygen treatment improves pancreatic β‑cell function and hepatic gluconeogenesis in STZ‑induced type‑2 diabetes mellitus model mice.
Zhang C; Zhang D; Wang H; Lin Q; Li M; Yuan J; Gao G; Dong J
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039874
[TBL] [Abstract][Full Text] [Related]
3. Hyperbaric oxygen therapy affects insulin sensitivity/resistance by increasing adiponectin, resistin, and plasminogen activator inhibitor-I in rats.
Kahraman C; Yaman H
Turk J Med Sci; 2021 Jun; 51(3):1572-1578. PubMed ID: 33705641
[TBL] [Abstract][Full Text] [Related]
4. Bioactive compounds from Prosthechea karwinskii decrease obesity, insulin resistance, pro-inflammatory status, and cardiovascular risk in Wistar rats with metabolic syndrome.
Barragán-Zarate GS; Alexander-Aguilera A; Lagunez-Rivera L; Solano R; Soto-Rodríguez I
J Ethnopharmacol; 2021 Oct; 279():114376. PubMed ID: 34181956
[TBL] [Abstract][Full Text] [Related]
5. Dietary sucrose regulates the expression of the Cd36 gene in hepatic tissue of rats with obesity and Non Alcoholic Fatty Liver Disease (NAFLD).
Castro RQ; Soto Rodriguez I; Deschamps Lago RA; Pagola PG; Rodriguez Antolin J; Peres Quintal A; Rivera JR; Aguilera AA
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Jun; 162(2):99-106. PubMed ID: 29765172
[TBL] [Abstract][Full Text] [Related]
6. Hyperbaric oxygen therapy increases insulin sensitivity in overweight men with and without type 2 diabetes.
Wilkinson D; Nolting M; Mahadi MK; Chapman I; Heilbronn L
Diving Hyperb Med; 2015 Mar; 45(1):30-6. PubMed ID: 25964036
[TBL] [Abstract][Full Text] [Related]
7. Hyperbaric oxygen exposure alleviate metabolic side-effects of olanzapine treatment and is associated with Langerhans islet proliferation in rats.
AlQudah M; Khalifeh M; Al-Azaizeh R; Masaadeh A; Al-Rusan OM; Haddad HK
Pathol Oncol Res; 2022; 28():1610752. PubMed ID: 36590387
[No Abstract] [Full Text] [Related]
8. Advantages and disadvantages of hyperbaric oxygen treatment in mice with obesity hyperlipidemia and steatohepatitis.
Tsuneyama K; Chen YC; Fujimoto M; Sasaki Y; Suzuki W; Shimada T; Iizuka S; Nagata M; Aburada M; Chen SY
ScientificWorldJournal; 2011; 11():2124-35. PubMed ID: 22125461
[TBL] [Abstract][Full Text] [Related]
9. Hyperbaric oxygen but not hyperbaric air increases insulin sensitivity in men with type 2 diabetes mellitus.
Wilkinson DC; Chapman IM; Heilbronn LK
Diving Hyperb Med; 2020 Dec; 50(4):386-390. PubMed ID: 33325020
[TBL] [Abstract][Full Text] [Related]
10. Hyperbaric oxygen therapy improves age induced bone dyshomeostasis in non-obese and obese conditions.
Imerb N; Thonusin C; Pratchayasakul W; Arunsak B; Nawara W; Aeimlapa R; Charoenphandhu N; Chattipakorn N; Chattipakorn SC
Life Sci; 2022 Apr; 295():120406. PubMed ID: 35182555
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the Impact of Different Hypercaloric Diets on Weight Gain, Insulin Resistance, Glucose Intolerance, and its Comorbidities in Rats.
Melo BF; Sacramento JF; Ribeiro MJ; Prego CS; Correia MC; Coelho JC; Cunha-Guimaraes JP; Rodrigues T; Martins IB; Guarino MP; Seiça RM; Matafome P; Conde SV
Nutrients; 2019 May; 11(6):. PubMed ID: 31141900
[TBL] [Abstract][Full Text] [Related]
12. Hyperbaric oxygen therapy effectively alleviates D-galactose-induced-age-related cardiac dysfunction via attenuating mitochondrial dysfunction in pre-diabetic rats.
Bo-Htay C; Shwe T; Jaiwongkam T; Kerdphoo S; Pratchayasakul W; Pattarasakulchai T; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Aging (Albany NY); 2021 Apr; 13(8):10955-10972. PubMed ID: 33861726
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and behavioural effects of sucrose and fructose/glucose drinks in the rat.
Sheludiakova A; Rooney K; Boakes RA
Eur J Nutr; 2012 Jun; 51(4):445-54. PubMed ID: 21800086
[TBL] [Abstract][Full Text] [Related]
14. Role of fatty acid composition in the development of metabolic disorders in sucrose-induced obese rats.
Fukuchi S; Hamaguchi K; Seike M; Himeno K; Sakata T; Yoshimatsu H
Exp Biol Med (Maywood); 2004 Jun; 229(6):486-93. PubMed ID: 15169967
[TBL] [Abstract][Full Text] [Related]
15. Effect of Hyperbaric Oxygen Therapy on Fatty Acid Composition and Insulin-like Growth Factor Binding Protein 1 in Adult Type 1 Diabetes Mellitus Patients: A Pilot Study.
Resanović I; Gluvić Z; Zarić B; Sudar-Milovanović E; Vučić V; Arsić A; Nedić O; Šunderić M; Gligorijević N; Milačić D; Isenović ER
Can J Diabetes; 2020 Feb; 44(1):22-29. PubMed ID: 31311728
[TBL] [Abstract][Full Text] [Related]
16. Effect of Korean Red Ginseng on metabolic syndrome.
Yoon SJ; Kim SK; Lee NY; Choi YR; Kim HS; Gupta H; Youn GS; Sung H; Shin MJ; Suk KT
J Ginseng Res; 2021 May; 45(3):380-389. PubMed ID: 34025131
[TBL] [Abstract][Full Text] [Related]
17. Assessment of insulin sensitivity during hyperbaric oxygen treatment.
Wilkinson D; Szekely S; Gue B; Tam CS; Chapman I; Heilbronn LK
Diving Hyperb Med; 2020 Sep; 50(3):238-243. PubMed ID: 32957125
[TBL] [Abstract][Full Text] [Related]
18. Effect of Glycine on Adipocyte Hypertrophy in a Metabolic Syndrome Rat Model.
López YR; Pérez-Torres I; Zúñiga-Muñoz A; Lans VG; Díaz-Díaz E; Castro ES; Espejel RV
Curr Drug Deliv; 2016; 13(1):158-69. PubMed ID: 26996629
[TBL] [Abstract][Full Text] [Related]
19. Two unhealthy dietary habits featuring a high fat content and a sucrose-containing beverage intake, alone or in combination, on inducing metabolic syndrome in Wistar rats and C57BL/6J mice.
Chen GC; Huang CY; Chang MY; Chen CH; Chen SW; Huang CJ; Chao PM
Metabolism; 2011 Feb; 60(2):155-64. PubMed ID: 20045537
[TBL] [Abstract][Full Text] [Related]
20. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
